SECsense Logo

TransMedics Group, Inc. 8-K Report: Key Updates for Investors (Feb 20, 2025)

$TMDX
Form 8-K
Filed on: 2025-02-21
Source
TransMedics Group, Inc. 8-K Report: Key Updates for Investors (Feb 20, 2025)

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: TransMedics Group, Inc.
  • CIK (Central Index Key): 0001756262
  • State of Incorporation: Massachusetts (MA)
  • SEC File Number: 001-38891
  • Employer Identification Number (EIN): 83-2181531
  • Address: 200 Minuteman Road, Andover, MA 01810
  • Phone Number: (978) 552-0900
  1. Filing Details:
  • Filing Type: 8-K (Current Report)
  • Filing Date: February 20, 2025
  1. Stock Information:
  • Class of Securities: Common Stock, no par value per share
  • Ticker Symbol: TMDX
  • Exchange: NASDAQ
  1. Report Context:
  • Period: The report covers a specific date, February 20, 2025.
  • Duration Context ID: duration_2025-02-20_to_2025-02-20 indicates that the period of reporting is one day.

Insights:

  • The filing is a current report (8-K), typically used to announce major events that shareholders should know about, which may indicate significant updates regarding the company's operations or financial situation.
  • Being listed on NASDAQ under the ticker TMDX suggests that TransMedics is a publicly traded company, which may attract investors looking for opportunities in the medical technology sector.
  • The specific date of the report might suggest that it includes timely information relevant to recent events or announcements made by the company on that date.

Overall, this section indicates a formal disclosure by TransMedics Group, Inc. that could have implications for investors and stakeholders. Further analysis would require examination of the full content of the 8-K filing to understand the nature of the disclosure.